FDA pushes back Natpara PDUFA

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said FDA has delayed the PDUFA date for Natpara from Oct. 24 to Jan. 24, 2015, to review a major amendment to the BLA. NPS said the agency has also asked for a REMS and will likely require a post-approval study.

The announcement came after market close; NPS shares were up $1.42 to $29.08 on Thursday. ...